Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review

[1]  Heleen M A Hendriksen,et al.  LDL cholesterol and uridine levels in blood are potential nutritional biomarkers of AD progression: The NUDAD project , 2020 .

[2]  K. Blennow,et al.  36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[3]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[4]  T. Schöneberg,et al.  Update of P2Y receptor pharmacology: IUPHAR Review 27 , 2020, British journal of pharmacology.

[5]  R. Bekdash.  Neuroprotective Effects of Choline and Other Methyl Donors , 2019, Nutrients.

[6]  J. Salonen,et al.  Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2019, The American journal of clinical nutrition.

[7]  David A Bennett,et al.  Diagnosis and Management of Dementia: Review. , 2019, JAMA.

[8]  M. Inazu.  Functional Expression of Choline Transporters in the Blood–Brain Barrier , 2019, Nutrients.

[9]  D. Alkon,et al.  Neuro-regeneration Therapeutic for Alzheimer's Dementia: Perspectives on Neurotrophic Activity. , 2019, Trends in pharmacological sciences.

[10]  G. Gilmour,et al.  Targeting the Synapse in Alzheimer’s Disease , 2019, Front. Neurosci..

[11]  M. Roberts,et al.  Working Memory and Inadequate Micronutrient Consumption in Healthy Seniors , 2019, Journal of nutrition in gerontology and geriatrics.

[12]  H. Soininen,et al.  Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) , 2019, Alzheimer's Research & Therapy.

[13]  D. Hervás,et al.  Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker. , 2019, Journal of proteomics.

[14]  O. Forlenza,et al.  Plasma lipids metabolism in mild cognitive impairment and Alzheimer’s disease , 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[15]  N. Ip,et al.  Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies. , 2019, Pharmacology & therapeutics.

[16]  N. Scarmeas,et al.  Dietary interventions in mild cognitive impairment and dementia , 2019, Dialogues in clinical neuroscience.

[17]  N. Scarmeas,et al.  Nutrition and prevention of cognitive impairment , 2018, The Lancet Neurology.

[18]  J. Blusztajn,et al.  Choline , 2018, Nutrition Today.

[19]  A. Wojtczak,et al.  Role of purinergic receptors in the Alzheimer’s disease , 2018, Purinergic Signalling.

[20]  B. McGuinness,et al.  Effect of dietary interventions in mild cognitive impairment: a systematic review , 2018, British Journal of Nutrition.

[21]  M. Mesulam,et al.  The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. , 2018, Brain : a journal of neurology.

[22]  Ronald C. Petersen,et al.  Practice guideline update summary: Mild cognitive impairment , 2018, Neurology.

[23]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[24]  R. Wurtman.  Synapse formation in the brain can be enhanced by co-administering three specific nutrients. , 2017, European journal of pharmacology.

[25]  K. Blennow,et al.  24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial , 2017, The Lancet Neurology.

[26]  B. McGuinness,et al.  The effect of diet, lifestyle and/or cognitive interventions in Mild Cognitive Impairment: a systematic review , 2017, Proceedings of the Nutrition Society.

[27]  Michael W. Weiner,et al.  Metabolic network failures in Alzheimer's disease: A biochemical road map , 2017, Alzheimer's & Dementia.

[28]  A. Smit,et al.  High Content Analysis of Hippocampal Neuron-Astrocyte Co-cultures Shows a Positive Effect of Fortasyn Connect on Neuronal Survival and Postsynaptic Maturation , 2017, Front. Neurosci..

[29]  C. Jack,et al.  Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers , 2017, The Lancet Neurology.

[30]  H. Soininen,et al.  Nutrient intake and dietary changes during a 2-year multi-domain lifestyle intervention among older adults: secondary analysis of the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) randomised controlled trial. , 2017, The British journal of nutrition.

[31]  J. Blusztajn,et al.  Neuroprotective Actions of Dietary Choline , 2017, Nutrients.

[32]  B. Vellas,et al.  Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses , 2017, Alzheimer's & dementia.

[33]  D. Michaelson,et al.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer’s disease: a rationale for multi-nutrient dementia prevention , 2017, Journal of Lipid Research.

[34]  W. M. van der Flier,et al.  Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia , 2017, Alzheimer's & dementia.

[35]  S. Lehéricy,et al.  Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial , 2017, The Lancet Neurology.

[36]  L. Facci,et al.  Synaptic Plasticity, Dementia and Alzheimer Disease. , 2017, CNS & neurological disorders drug targets.

[37]  L. Schneider,et al.  Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E &egr;4 Carriers: A Review , 2017, JAMA neurology.

[38]  M. Nalls,et al.  What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease , 2017, Neurobiology of Aging.

[39]  Michelle K. Lupton,et al.  Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis , 2017, Alzheimer's & Dementia.

[40]  L. Tsai,et al.  The road to restoring neural circuits for the treatment of Alzheimer's disease , 2016, Nature.

[41]  E. Boerwinkle,et al.  Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study , 2016, Alzheimer's & dementia.

[42]  V. Gudnason,et al.  Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals , 2016, Alzheimer's & Dementia.

[43]  L. Schneider,et al.  The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[44]  E. Masliah,et al.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability , 2016, Alzheimer's & Dementia.

[45]  S. Patassini,et al.  Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder , 2016, Biochimica et biophysica acta.

[46]  C. Barbas,et al.  Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer's Disease and Mild Cognitive Impairment. , 2016, Current Alzheimer research.

[47]  E. Boerwinkle,et al.  Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS) , 2016, Alzheimer's & dementia.

[48]  I. Kügelgen,et al.  Pharmacology and structure of P2Y receptors , 2016, Neuropharmacology.

[49]  Jeffrey Cummings,et al.  ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[50]  A. Heerschap,et al.  The effect of Souvenaid on brain phospholipid metabolism in patients with mild Alzheimer’s disease: results of a randomised controlled 31P-Magnetic Resonance Spectroscopy study , 2016, Neurobiology of Aging.

[51]  Yingjun Li,et al.  Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. , 2015, The American journal of clinical nutrition.

[52]  H. Tanila,et al.  Lipid-Based Diets Improve Muscarinic Neurotransmission in the Hippocampus of Transgenic APPswe/PS1dE9 Mice. , 2015, Current Alzheimer research.

[53]  P. Calder,et al.  No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer’s Disease: A Randomised Controlled Trial , 2015, International journal of molecular sciences.

[54]  D. Bennett,et al.  Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease , 2015, Alzheimer's Research & Therapy.

[55]  G. Kemmler,et al.  The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment , 2015, Alzheimer's & dementia.

[56]  Brooke L. Barnette,et al.  Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer’s disease subjects , 2015, Acta Neuropsychiatrica.

[57]  C. Hölscher,et al.  Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease , 2015, PloS one.

[58]  J. Sijben,et al.  A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats , 2015, Neurobiology of Aging.

[59]  K. Langa,et al.  The diagnosis and management of mild cognitive impairment: a clinical review. , 2014, JAMA.

[60]  J L Gómez-Ariza,et al.  Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry. , 2014, Journal of pharmaceutical and biomedical analysis.

[61]  T. Stijnen,et al.  Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis , 2014, Alzheimer's & Dementia.

[62]  J. Gómez-Ariza,et al.  Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease. , 2014, Journal of proteomics.

[63]  D. Vance.  Phospholipid methylation in mammals: from biochemistry to physiological function. , 2014, Biochimica et biophysica acta.

[64]  W. Xu,et al.  Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment. , 2014, Journal of proteome research.

[65]  Derick R. Peterson,et al.  Plasma phospholipids identify antecedent memory impairment in older adults , 2014, Nature Medicine.

[66]  H. Soininen,et al.  Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease , 2014, Neurobiology of Aging.

[67]  S. Engelborghs,et al.  Rationale and clinical data supporting nutritional intervention in Alzheimer’s disease , 2014, Acta clinica Belgica.

[68]  H. Tanila,et al.  Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition. , 2014, The Journal of nutritional biochemistry.

[69]  Stephen A. Rappaport,et al.  The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease , 2013, Alzheimer's Research & Therapy.

[70]  P. Kamphuis,et al.  Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.

[71]  X. Arakaki,et al.  Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease[S] , 2013, Journal of Lipid Research.

[72]  Masaru Tomita,et al.  Capillary electrophoresis‐mass spectrometry‐based metabolome analysis of serum and saliva from neurodegenerative dementia patients , 2013, Electrophoresis.

[73]  L. Joosten,et al.  Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice , 2013, PloS one.

[74]  Oliver Fiehn,et al.  A new metabolomic workflow for early detection of Alzheimer's disease. , 2013, Journal of chromatography. A.

[75]  P. Dederen,et al.  Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice , 2013, Brain Structure and Function.

[76]  P. Kamphuis,et al.  Combined nutrient supplementation enhances neurite outgrowth and synaptic protein expression in vitro , 2013, Alzheimer's & Dementia.

[77]  Ronald C. Petersen,et al.  Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics , 2013, PloS one.

[78]  P. Fagone,et al.  Phosphatidylcholine and the CDP-choline cycle. , 2013, Biochimica et biophysica acta.

[79]  S. Vollset,et al.  Plasma free choline, betaine and cognitive performance: the Hordaland Health Study. , 2013, The British journal of nutrition.

[80]  P. Kamphuis,et al.  A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice. , 2012, Journal of Alzheimer's disease : JAD.

[81]  Steven R. Brenner,et al.  Penetrance of PD in Glucocerebrosidase Gene Mutation Carriers , 2012, Neurology.

[82]  K. Herholz,et al.  Cholinergic system function and cognition in mild cognitive impairment , 2012, Neurobiology of Aging.

[83]  C. DeCarli,et al.  Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging , 2012, Neurology.

[84]  H. Hampel,et al.  Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid , 2012, PloS one.

[85]  P. Kamphuis,et al.  A specific multi‐nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro , 2012, Journal of neurochemistry.

[86]  H. Soininen,et al.  Metabolome in progression to Alzheimer's disease , 2011, Translational Psychiatry.

[87]  P. Wolf,et al.  The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. , 2011, The American journal of clinical nutrition.

[88]  H. Tanila,et al.  From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. , 2011, Journal of chromatography. A.

[89]  P. Kamphuis,et al.  Multi-nutrient supplementation induces changes in synaptic protein expression , 2011, Alzheimer's & Dementia.

[90]  Romana Höftberger,et al.  Peroxisomal alterations in Alzheimer’s disease , 2011, Acta Neuropathologica.

[91]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[92]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[93]  G. Juhász,et al.  Uridine function in the central nervous system. , 2011, Current topics in medicinal chemistry.

[94]  T. Hartmann,et al.  Plasmalogen synthesis is regulated via alkyl‐dihydroxyacetonephosphate‐synthase by amyloid precursor protein processing and is affected in Alzheimer’s disease , 2011, Journal of neurochemistry.

[95]  P. Renshaw,et al.  Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T. , 2010, Bipolar disorders.

[96]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[97]  Terry K. Smith,et al.  The Kennedy pathway—De novo synthesis of phosphatidylethanolamine and phosphatidylcholine , 2010, IUBMB life.

[98]  P. Scheltens,et al.  Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial , 2010, Alzheimer's & Dementia.

[99]  R. Wurtman,et al.  Use of phosphatide precursors to promote synaptogenesis. , 2009, Annual review of nutrition.

[100]  R. Mayeux,et al.  Mediterranean diet and mild cognitive impairment. , 2009, Archives of neurology.

[101]  Amy J. Ross,et al.  Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy , 2008, NMR in biomedicine.

[102]  M. Selley.  A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease , 2007, Neurobiology of Aging.

[103]  R. Wurtman,et al.  Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus , 2007, Brain Research.

[104]  Kevin F Krenitsky,et al.  Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia Published, JLR Papers in Press, August 2, 2007. , 2007, Journal of Lipid Research.

[105]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[106]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[107]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[108]  R. Benedictus,et al.  Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells , 2005, Neuroscience.

[109]  R. Brookmeyer,et al.  Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging , 2005, Alzheimer's & Dementia.

[110]  P. Scheltens,et al.  Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer’s disease , 2003, Journal of Neural Transmission.

[111]  D. Bennett,et al.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.

[112]  B. Heude,et al.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.

[113]  D. Bennett,et al.  Dietary fats and the risk of incident Alzheimer disease. , 2003, Archives of neurology.

[114]  Y. Moriwaki,et al.  Effect of beer on the plasma concentrations of uridine and purine bases. , 2002, Metabolism: clinical and experimental.

[115]  S. Wisniewski,et al.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment , 2002, Annals of neurology.

[116]  J. Pettegrew,et al.  Brain Membrane Phospholipid Alterations in Alzheimer's Disease , 2001, Neurochemical Research.

[117]  Xianlin Han,et al.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.

[118]  R. Wurtman,et al.  Effect of oral CDP-choline on plasma choline and uridine levels in humans. , 2000, Biochemical pharmacology.

[119]  K. Xiao,et al.  Activity of phosphatidylethanolamine-N-methyltransferase in brain affected by Alzheimers disease , 1999, Neurochemistry International.

[120]  R. Ravid,et al.  Reduced Levels of Cholesterol, Phospholipids, and Fatty Acids in Cerebrospinal Fluid of Alzheimer Disease Patients Are Not Related to Apolipoprotein E4 , 1998, Alzheimer disease and associated disorders.

[121]  G. P. Connolly.  Fibroblast models of neurological disorders: fluorescence measurement studies. , 1998, Trends in pharmacological sciences.

[122]  Stanley I. Rapoport,et al.  Membrane Phospholipid Alterations In Alzheimer's Disease: Deficiency of Ethanolamine Plasmalogens , 1997, Neurochemical Research.

[123]  C. Gottfries,et al.  Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type , 1996, International Psychogeriatrics.

[124]  H. Lieberman,et al.  Citicoline improves verbal memory in aging. , 1996, Archives of neurology.

[125]  S. Rapoport,et al.  Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain , 1995, Brain Research.

[126]  A. Stoll,et al.  Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. , 1995, JAMA.

[127]  J. Growdon,et al.  Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[128]  F. Buonanno,et al.  In Vitro31P NMR Spectroscopy Detects Altered Phospholipid Metabolism in Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[129]  E. Helmes,et al.  Double Blind Study of Lecithin in Patients with Alzheimer's Disease * , 1981, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[130]  L. Thal,et al.  Choline chloride fails to improve cognition in Alzheimer's disease , 1981, Neurobiology of Aging.

[131]  R. Handschumacher,et al.  Novel single-pass exchange of circulating uridine in rat liver. , 1981, Science.

[132]  M. Baquero,et al.  Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: diagnosis utility. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[133]  Harald Hampel,et al.  Revisiting the Cholinergic Hypothesis in Alzheimer’s Disease: Emerging Evidence from Translational and Clinical Research , 2018, The Journal of Prevention of Alzheimer's Disease.

[134]  G. Logroscino,et al.  Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review. , 2017, Journal of Alzheimer's disease : JAD.

[135]  C. Antunez,et al.  A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[136]  P. Scheltens,et al.  Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study. , 2015, Journal of Alzheimer's disease : JAD.

[137]  J. Kaye,et al.  Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[138]  P. Scheltens,et al.  Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls. , 2014, Journal of Alzheimer's disease : JAD.

[139]  Carlo Caltagirone,et al.  Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[140]  A. Garthe,et al.  Improved spatial learning strategy and memory in aged Alzheimer AβPPswe/PS1dE9 mice on a multi-nutrient diet. , 2013, Journal of Alzheimer's disease : JAD.

[141]  Cornelis J Stam,et al.  Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. , 2012, Journal of Alzheimer's disease : JAD.

[142]  S. Rapoport,et al.  Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. , 2011, Journal of Alzheimer's disease : JAD.

[143]  B. Penke,et al.  Neuroprotective effects of a specific multi-nutrient intervention against Aβ42-induced toxicity in rats , 2011, Alzheimer's & Dementia.

[144]  Julie A. Wood,et al.  Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients. , 2010, Journal of psychiatry & neuroscience : JPN.

[145]  R. Wurtman,et al.  Dietary uridine-5′-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats , 2007, Journal of Molecular Neuroscience.

[146]  R. Benedictus,et al.  Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 [corrected]. , 2005, Neuroscience.

[147]  W. Markesbery,et al.  Regional Membrane Phospholipid Alterations in Alzheimer's Disease , 2004, Neurochemical Research.

[148]  M. Moreno.  Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. , 2003 .

[149]  G. P. Connolly.  Abnormal pyrimidine metabolism is the basis of some neurological diseases. , 1998, TIPS - Trends in Pharmacological Sciences.

[150]  M. Ganguli,et al.  Practice guideline update summary: Mild cognitive impairment Report of theGuidelineDevelopment, Dissemination, and Implementation Subcommittee of the American Academy ofNeurology , 2022 .